4D Molecular Therapeutics, Inc. - Common Stock (FDMT)
CUSIP: 35104E100
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 50,943,214
- Total 13F shares
- 16,612,608
- Share change
- +1,228,094
- Total reported value
- $400,026,000
- Price per share
- $24.08
- Number of holders
- 54
- Value change
- +$731,531
- Number of buys
- 40
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 35104E100?
CUSIP 35104E100 identifies FDMT - 4D Molecular Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 35104E100:
Top shareholders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
7.7%
|
3,937,914
|
$170,827,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
2.5%
|
1,287,571
|
$55,854,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.4%
|
1,227,397
|
$50,690,000 | — | 31 Mar 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2.1%
|
1,048,189
|
$45,471,000 | — | 31 Mar 2021 | |
| BVF INC/IL |
13F
|
Company |
2%
|
1,031,070
|
$44,728,000 | — | 31 Mar 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
2%
|
995,354
|
$43,178,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
547,404
|
$23,747,000 | — | 31 Mar 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.87%
|
444,878
|
$19,298,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.86%
|
437,262
|
$18,969,000 | — | 31 Mar 2021 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.79%
|
402,926
|
$17,479,000 | — | 31 Mar 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.74%
|
378,288
|
$16,410,000 | — | 31 Mar 2021 | |
| SB Management Ltd |
13F
|
Company |
0.68%
|
347,910
|
$15,092,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.66%
|
334,149
|
$14,495,000 | — | 31 Mar 2021 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.59%
|
300,886
|
$13,052,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.55%
|
279,746
|
$12,135,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.54%
|
276,294
|
$11,986,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
272,146
|
$11,805,000 | — | 31 Mar 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.39%
|
200,000
|
$8,676,000 | — | 31 Mar 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.31%
|
157,500
|
$6,832,000 | — | 31 Mar 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.29%
|
150,000
|
$6,507,000 | — | 31 Mar 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.29%
|
150,000
|
$6,507,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.29%
|
150,000
|
$6,507,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
146,298
|
$6,346,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.21%
|
106,833
|
$4,634,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.18%
|
90,251
|
$3,914,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
87,143
|
$3,780,000 | — | 31 Mar 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.17%
|
86,100
|
$3,735,000 | — | 31 Mar 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.17%
|
85,829
|
$3,723,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
57,967
|
$2,515,000 | — | 31 Mar 2021 | |
| Eagle Health Investments LP |
13F
|
Company |
0.1%
|
50,000
|
$2,169,000 | — | 31 Mar 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.06%
|
31,473
|
$1,365,000 | — | 31 Mar 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
27,448
|
$1,191,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
20,871
|
$905,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
20,592
|
$893,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
20,417
|
$885,000 | — | 31 Mar 2021 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.04%
|
20,000
|
$868,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
19,616
|
$851,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
18,760
|
$814,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
17,731
|
$769,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.02%
|
12,643
|
$548,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
12,486
|
$542,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
11,737
|
$509,000 | — | 31 Mar 2021 | |
| M&T BANK CORP |
13F
|
Company |
0.02%
|
10,495
|
$455,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
9,711
|
$422,000 | — | 31 Mar 2021 | |
| Resolute Advisors LLC |
13F
|
Company |
0.02%
|
9,600
|
$416,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,877
|
$297,000 | — | 31 Mar 2021 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.01%
|
5,935
|
$257,000 | — | 31 Mar 2021 | |
| CAPSTONE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.01%
|
5,879
|
$255,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
5,856
|
$254,000 | — | 31 Mar 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.01%
|
5,000
|
$217,000 | — | 31 Mar 2021 |
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock (FDMT) as of Q2 2021
As of 30 Jun 2021,
4D Molecular Therapeutics, Inc. - Common Stock (FDMT) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,612,608 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BVF INC/IL, JANUS HENDERSON GROUP PLC, Casdin Capital, LLC, FMR LLC, ArrowMark Colorado Holdings LLC, Aquilo Capital Management, LLC, Octagon Capital Advisors LP, BlackRock Inc., and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
63
Q2 2021 holders
54
Holder diff
-9
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.